Bayley, R, Sweatman, E & Higgs, M 2023, 'New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers', Cancer drug resistance (Alhambra, Calif.), vol. 6, pp. 35-44. https://doi.org/10.20517/cdr.2022.73
Bayley, R, Borel, V, Moss, R, Sweatman, E, Ruis, P, Ormrod, A, Goula, A, Mottram, R, Stanage, T, Hewitt, G, Saponaro, M, Stewart, G, Boulton, S & Higgs, M 2022, 'H3K4 methylation by SETD1A/BOD1L facilitates RIF1-dependent NHEJ', Molecular Cell, vol. 82, no. 10, pp. 1924-1939.e10. https://doi.org/10.1016/j.molcel.2022.03.030
Bayley R*,Ward C, García P, MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta, Reviews on Cancer, 2020, Dec;1874(2):188407 *=co-corresponding author
Volpe G, Cauchy P, Walton DS, Ward C, Blakemore D, Bayley R, Clarke ML, Schmidt L, Nerlov C, García P, Dumon S, Grebien F, Frampton J. Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations. Life Science Alliance, 2019, Mar 15;2(2)
Bayley R, Blakemore D, Cancian L, Dumon S, Volpe G, Ward C, Almaghrabi R, Gujar J, Reeve N, Raghavan M, Higgs MR, Stewart GS, Petermann E, García P. MYBL2 supports DNA double strand break repair in haematopoietic stem cells. Cancer Research, 2018, doi: 10.1158/0008-5472.CAN-18-0273. [Epub ahead of print]
Higgs MR, Sato K, Reynolds JJ, Begum S, Bayley R, Goula A, Vernet A, Paquin KL, Skalnik DG, Kobayashi W, Takata M, Howlett NG, Kurumizaka H, Kimura H, Stewart GS. Histone methylation by SETD1A protects nascent DNA through the nucleosome chaperone activity of FANCD2. Molecular Cell, 2018, 71(1): 25-41
Bayley R, Blakemore D, García P, MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome. Oncotarget, 2018, Vol. 9, (No. 101), pp: 37460-37461
Begum S, Goula A, Bayley R, Higgs MR, On your marks, get SET(D1A): the race to protect stalled replication forks. Molecular and Cellular Oncology, 2018, doi:10.1080/23723556.2018.1511209
Bayley R* and García P, DNA repair mechanisms in stem cells and their implications during ageing. Textbook Chapter in DNA Repair and Replication: Mechanisms and Clinical Significance, 2018, Chapter 14 * = co-corresponding author
Bayley R, Ahmed F, Glen K, McCall M, Stacey A, Thomas R. The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors. Journal of Tissue Engineering and Regenerative Medicine, 2017, 10.1002/term.2337
Bayley R, Kite KA, McGettrick HM, Smith JP, Kitas GD, Buckley CD, Young SP. The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in rheumatoid arthritis patients and healthy controls. Annals of the Rheumatic Diseases, 2015, Aug; 74(8):1588-95
Bayley R, Yang P, Buckley CD, Young SP. Measuring the activity of the protein tyrosine phosphatase Lyp. Journal of Immunological Methods, 2013, 388: 1-2, p33-39
Rider DA, Bayley R, Clay E, Young SP. Does Oxidative Inactivation of CD45 Phosphatase in Rheumatoid Arthritis Underlie Immune Hyporesponsiveness? Antioxidants and Redox Signalling, 2013, 19(18):2280-5
Richa D, Naylor A, Young SP, Bayley R, Hardie D, Haworth O, Rider DA, Cook A, Buckley CD, Kellie S, Differential Expression of CD148 on leucocyte subsets in inflammatory arthritis. Arthritis Research and Therapy, 2013, 15:R108
Juarez M, Scheel Toellner D, Karouzakis E, Hardy R, Yeo L, Bayley R, de Paz B, Raza K, Cooper M, Gay S, Buckley CD, Filer A, Early rheumatoid arthritis and resolving fibroblasts segregate according to Dickkopf related protein 1 expression. The Lancet, 2013, p57
Kapoor S, Fitzpatrick M, Clay E, Bayley R, Wallace GR, Young SP, Metabolomics in the analysis of inflammatory diseases. Textbook chapter in Metabolomics, 2012, Chapter 11; pages 269-288
View all publications in research portal